CAROLYN FALLICA: Open Payments
NPI 1447241757 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 9 payments from 8 companies in 2025. Trend: 2023 $356 · 2024 $372 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $58 |
| Genentech USA, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
| Novocure Inc. | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $16 |
| ConvaTec Inc. | 1 | $14 |
Products named: RYBREVANT, Phesgo, DARZALEX, JEMPERLI, SARCLISA, Optune Lua (NovoTTF-200T), Leqembi, AQUACEL AG+ EXTRA.
Industry payments across MA — which companies pay providers there.
